Queens Cancer Center of Queens Hospital
Jamaica, New York 11432
4 studies enrolling now · 57 studies all time
What they study most
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Promyelocytic Leukemia, Anxiety Disorder, Bladder Cancer, Breast Adenocarcinoma, Breast Cancer, Central Nervous System (CNS) Metastases, Childhood Germ Cell Tumor, Chinese Immigrants With Breast Cancer, Chronic Leukemia, Colon Cancer
Studies at this site
- Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients — Recruiting now
- Phase IIIb Study of Ribociclib + ET in Early Breast Cancer — Recruiting now
- Genomic Profiling in Cancer Patients — Recruiting now
- Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job — Recruiting now
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer — Completed
- Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma — Completed
- Vitamin D and Breast Cancer Biomarkers in Female Patients — Completed
- Early Onset and Familial Gastric Cancer Registry — Completed
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes — Status unconfirmed
- Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia — Running, not enrolling
- Physician Use of Non-English Language Skills in Cancer Care — Completed
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery — Stopped early
- A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Participants With Advanced Breast Cancer — Completed
- Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia — Completed
- Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer — Completed
- Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720 — Completed
- Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer — Completed
- Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases — Completed
- Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer — Completed
- Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma — Completed
- Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement — Completed
- FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum — Stopped early
- Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer — Completed
- Collection of Patient-Reported Symptoms and Performance Status Via the Internet — Completed
- Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer — Completed
- Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer — Completed
- Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer — Stopped early
- Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer — Completed
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer — Completed
- Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma — Completed
- Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver — Completed
- Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer — Completed
- Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma — Completed
- Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma — Completed
- Docetaxel in Treating Patients With Solid Tumors — Completed
- Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia — Completed
- Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer — Completed
- Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas — Completed
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma — Completed
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma — Completed
- Surgery in Treating Patients With Prostate Cancer — Completed
- Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy — Completed
- Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer — Completed
- Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma — Completed
- Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors — Stopped early
- Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer — Completed
- Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy — Completed
- PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma — Completed
- Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer — Completed
- Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer — Completed